Status:
UNKNOWN
Population Pharmacokinetics and Metabolomics of Theophylline in Preterm Infants
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Seoul National University Bundang Hospital
Seoul National University Boramae Hospital
Conditions:
Apea of Prematurity
Eligibility:
All Genders
Up to 37 years
Brief Summary
1. Population pharmacokinetics : The purpose of this study is \- to investigate the population pharmacokinetics of theophylline in premature Korean infants and to assess the influence of demograph...
Eligibility Criteria
Inclusion
- Inborn preterm infants (GA \< 37 weeks)
- Dx : Apnea of prematurity
- Tx : Aminophylline / Theophylline
- Informed consent of parents
Exclusion
- Major congenital anomaly
- Expired within 72 hours
- Proven secondary apnea
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01509248
Start Date
May 1 2010
Last Update
February 23 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.